olmesartan medoxomil

Generic: olmesartan medoxomil

Labeler: cadila pharmaceuticals limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name olmesartan medoxomil
Generic Name olmesartan medoxomil
Labeler cadila pharmaceuticals limited
Dosage Form TABLET, COATED
Routes
ORAL
Active Ingredients

olmesartan medoxomil 20 mg/1

Manufacturer
Cadila Pharmaceuticals Limited

Identifiers & Regulatory

Product NDC 71209-080
Product ID 71209-080_c8a58add-6c59-47ff-94e2-12d4e6513feb
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA210682
Listing Expiration 2026-12-31
Marketing Start 2025-01-01

Pharmacologic Class

Classes
angiotensin 2 receptor antagonists [moa] angiotensin 2 receptor blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71209080
Hyphenated Format 71209-080

Supplemental Identifiers

RxCUI
349373 349401 349405
UNII
6M97XTV3HD

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name olmesartan medoxomil (source: ndc)
Generic Name olmesartan medoxomil (source: ndc)
Application Number ANDA210682 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 20 mg/1
source: ndc
Packaging
  • 30 TABLET, COATED in 1 BOTTLE (71209-080-01)
  • 90 TABLET, COATED in 1 BOTTLE (71209-080-04)
  • 500 TABLET, COATED in 1 BOTTLE (71209-080-10)
source: ndc

Packages (3)

Ingredients (1)

olmesartan medoxomil (20 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "c8a58add-6c59-47ff-94e2-12d4e6513feb", "openfda": {"unii": ["6M97XTV3HD"], "rxcui": ["349373", "349401", "349405"], "spl_set_id": ["c5416a9f-1dcc-4851-bbc0-6664d22fc8fa"], "manufacturer_name": ["Cadila Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, COATED in 1 BOTTLE (71209-080-01)", "package_ndc": "71209-080-01", "marketing_start_date": "20250101"}, {"sample": false, "description": "90 TABLET, COATED in 1 BOTTLE (71209-080-04)", "package_ndc": "71209-080-04", "marketing_start_date": "20250101"}, {"sample": false, "description": "500 TABLET, COATED in 1 BOTTLE (71209-080-10)", "package_ndc": "71209-080-10", "marketing_start_date": "20250101"}], "brand_name": "Olmesartan Medoxomil", "product_id": "71209-080_c8a58add-6c59-47ff-94e2-12d4e6513feb", "dosage_form": "TABLET, COATED", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]"], "product_ndc": "71209-080", "generic_name": "Olmesartan Medoxomil", "labeler_name": "Cadila Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Olmesartan Medoxomil", "active_ingredients": [{"name": "OLMESARTAN MEDOXOMIL", "strength": "20 mg/1"}], "application_number": "ANDA210682", "marketing_category": "ANDA", "marketing_start_date": "20250101", "listing_expiration_date": "20261231"}